Feed aggregator

An amendment, offered by Mr. Lipinski, numbered 21 printed in Part B of House Report 115-295 to decrease the Office of the Secretary of Transportation Salaries and Expenses account by $9,000,000 and increase the National Highway Traffic Safety Administration's Salaries and Expenses account by the same amount for the purpose of expanding NHTSA's connected and automated vehicles oversight and regulatory capabilities.

On agreeing to the Diaz-Balart amendments; Agreed to by voice vote.

DEBATE - Pursuant to the provisions of H. Res. 500, the Committee of the Whole proceeded with 20 minutes of debate on the Diaz-Balart En Bloc amendment No. 2.

On agreeing to the King (IA) amendment; Agreed to by voice vote.

DEBATE - Pursuant to the provisions of H. Res. 500, the Committee of the Whole proceeded with 10 minutes of debate on the King (IA) amendment No. 18.

An amendment, offered by Mr. King (IA), numbered 18 printed in Part B House Report 115-295 to ensure that no funds may be used on new hires who have not been verified through the E-Verify program, except for an employee compensated under a local compensation plan established under section 408 of the Foreign Service Act of 1980.

POSTPONED PROCEEDINGS - At the conclusion of debate on the Carter (GA) amendment, the Chair put the question on adoption of the amendment and by voice vote announced that the ayes had prevailed. Ms. DeLauro demanded a recorded vote, and the Chair postponed further proceedings on the question of adoption of the amendment until a time to be announced.

DEBATE - Pursuant to the provisions of H. Res. 500, the Committee of the Whole proceeded with 10 minutes of debate on the Carter (GA) amendment No. 17.

An amendment, offered by Mr. Carter (GA), numbered 17 printed in House Report 115-295 to prohibit funds from being used by the Food and Drug Administration to finalize, implement, or enforce the draft standard memorandum of understanding made available for public comment on February 19, 2015, entitled "Draft Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products Between the State of [Insert State] and the U.S. Food and Drug Administration."

On agreeing to the Hartzler amendment; Agreed to by voice vote.

DEBATE - Pursuant to the provisions of H. Res. 500, the Committee of the Whole proceeded with 10 minutes of debate on the Hartzler amendment No. 16.

An amendment, offered by Mrs. Hartzler, numbered 16 printed in Part B of House Report 115-295 to prohibit the USDA from using funds to implement the Paid Lunch Equity provision in the National School Lunch Act.

POSTPONED PROCEEDINGS - At the conclusion of debate on the King (IA) amendment, the Chair put the question on adoption of the amendment and by voice vote announced that the ayes had prevailed. Mr. Bishop demanded a recorded vote, and the Chair postponed further proceedings on the question of adoption of the amendment until a time to be announced.

DEBATE - Pursuant to the provisions of H. Res. 500, the Committee of the Whole proceeded with 10 minutes of debate on the King (IA) amendment No. 15.

On agreeing to the Davis, Rodney amendment; Agreed to by voice vote.

DEBATE - Pursuant to the provisions of H. Res. 500, the Committee of the Whole proceeded with 10 minutes of debate on the Rodney Davis amendment No. 14.

An amendment, offered by Mr. Davis, Rodney, numbered 14 printed in Part B of House Report 115-295 to prohibit the use of funds provided by the Act to be used to revoke exceptions made pursuant to the rule entitled "Exceptions to Geographic Areas for Official Agencies Under the USGSA" on a date before April 14, 2017.

On agreeing to the Cicilline amendment; Agreed to by voice vote.

Amendments en bloc offered by Mr. Aderholt, comprised of the following amendments offered En bloc No. 1 : Amendments Nos. 1, 2, 3, 4, 5, 6, 7, 8, 9, 13, 19, and 20 printed in Part B of House Report 115-295.

DEBATE - Pursuant to the provisions of H. Res. 500, the Committee of the Whole proceeded with 20 minutes of debate on the Aderholt En Bloc amendment No. 1.